咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Current status of intestinal a... 收藏

Current status of intestinal and multivisceral transplantation

肠道移植和多脏器联合移植的现状

作     者:Shishira Bharadwaj Parul Tandon Tushar D.Gohel Jill Brown Ezra Steiger Donald F.Kirby Ajai Khanna Kareem Abu-Elmagd 

作者机构:Center for Gut Rehabilitation and Transplantationthe Cleveland Clinic FoundationClevelandOHUSA 

出 版 物:《Gastroenterology Report》 (胃肠病学报道(英文))

年 卷 期:2017年第5卷第1期

页      面:20-28,I0001页

核心收录:

学科分类:1011[医学-护理学(可授医学、理学学位)] 10[医学] 

主  题:intestinal transplant multivisceral transplant parenteral nutrition intestinal failure gut rehabilitation 

摘      要:Clinical-nutritional autonomy is the ultimate goal of patients with intestinal failure(IF).Traditionally,patients with IF have been relegated to lifelong parenteral nutrition(PN)once surgical and medical rehabilitation attempts at intestinal adaptation have *** the past two decades,however,outcome improvements in intestinal transplantation have added another dimension to the therapeutic armamentarium in the field of gut *** has become possible through relentless efforts in the standardization of surgical techniques,advancements in immunosuppressive therapies and induction protocols and improvement in postoperative patient *** types of intestinal transplants include isolated small bowel transplant,liver-small bowel transplant,multivisceral transplant and modified multivisceral *** guidelines restrict intestinal transplantation to patients who have had significant complications from PN including liver failure and repeated *** an experimental stage to the currently established therapeutic modality for patients with advanced IF,outcome improvements have also been possible due to the introduction of tacrolimus in the early *** have shown that intestinal transplant is cost-effective within 1–3 years of graft survival compared with *** survival and quality of life as well as resumption of an oral diet should enable intestinal transplantation to be an important option for patients with IF in addition to continued *** research should focus on detecting biomarkers of early rejection,enhanced immunosuppression protocols,improved postoperative care and early referral to transplant centers.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分